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ancer  in the  elderly
logic complications, decreased bone marrow reserves, andhe population in developed countries is aging and the propor-
ion of higher age categories in the age structure is increasing.
n the Czech Republic inhabitants aged over 70 years repre-
ented 7% of population in the year 1970, 10% in the year 2009
nd the expectation for the year 2030 is 25%. This percentage
s even higher in more  developed countries in Europe and in
he USA. The aging of the population unavoidably leads to a
rowing number of persons diagnosed and living with can-
er (Table 1). With improving treatment and better survival
f cancer patients also the number of second and third malig-
ancies is rising (Fig. 1). The dynamics of incidence of the most
requent malignant tumors in patients older than 70 years
s shown in Fig. 2. These patients represent 30–60% of newly
iagnosed malignancies and an even higher percentage of the
ancer death rate. The disease stages at diagnosis in patients
ged 70+ are shown in Fig. 3.
Fig. 1 – Incidence: ﬁrst and second malignanGrowing incidence and mortality of malignant diseases
in elderly patients together with an aging population brings
new, urgent problems into daily oncological practice. Already
some past articles in the Reports of Practical Oncology and
Radiotherapy have been devoted to this topic.1 The present
special issue is concentrated on some important aspects of
this subject.
Elderly people frequently suffer due to cardiovascular
disorders (myocardial infarctions, ischemic coronary dis-
ease with reduction of left ventricular function), pulmonary
disorders (changes in ventilation and perfusion, chronical
obstructive and restrictive changes), nephrologic and uro-cies in patients with colorectal cancer.
nutrition problems. Comorbidity in these patients has a deep
impact on the tolerance of all principal methods of oncolo-
gical treatment – surgery, radiotherapy and medical therapy.
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Table 1 – Epidemiology of selected cancer diseases.
Location
of cancer
Whole population Population 70+ years
Incidence
(2004-2008)
Mortality
(2004-2008)
Prevalence (at
31.12.2008)
Incidence
(2004-2008)
Mortality
(2004-2008)
Prevalence (at
31.12.2008)
Number of
cases per
year
Crude
rate per
100,000
Number of
cases per
year
Crude
rate per
100,000
Number of
cases
Crude
rate per
100,000
Number of
cases per
year
Crude
rate per
100,000
Number of
cases
Crude
rate per
100,000
Number of
cases per
year
Crude
rate per
100,000
Colon and
rectum
(C18-C20)
7939  76.9 4103 39.6 45,866 438.2 3975 384.7 2481 240.2 14,623 1392.4
Pancreas (C25) 1871 18.1 1781 17.3 1584 15.1 958 92.8 962 93.1 500 47.6
Head and neck
(C00-C14.C30-
C32)
1880 18.2 974 9.4 11,390 108.8 410 39.7 249 24.1 1699 161.8
Lung (C34) 6383 61.8 5517 53.5 10,139 96.9 2536 245.5 2387 231.0 2406 229.1
Melanoma of
skin (C43)
1839 17.8 337 3.3 18,743 179.1 596 57.7 156 15.1 3312 315.4
Female breast
(C50)
6074  115.1a 1833 34.7a 58,719 1101.4a 1939 297.7a 983 150.8a 11,041 1675.3a
Female
reproductive
system
(C53-C56)
4022  76.2a 1540 29.2a 48,029 900.9a 1218 187.0a 725 111.3a 5691 863.5a
Prostate (C61) 4952 98.1b 1366 27.1b 28,412 553.2b 2612 684.6b 1070 280.3b 12,995 3322.7b
Kidney (C64) 2785 27.0 1110 10.8 18,166 173.5 1099 106.4 591 57.2 4012 382.0
Stomach (C16) 1658 16.1 1282 12.4 4845 46.3 881 85.3 746 72.2 1556 148.2
a per 100,000 women.
b per 100,000 men.
nd ra
E
s
K
o
ireports of practical oncology a
lder age categories are underrepresented in most of clinical
tudies. A comprehensive review and analysis is provided by
azmierska.2In the absence of sufﬁcient data on tolerance and results
f anticancer therapy in senior citizens clinicians frequently
ndicate less intensive treatment in comparison with general
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guidelines. But age itself is not contraindicative of curative
oncological treatment and older patients with good perfor-
mance status and minimal comorbidity may the same beneﬁt
from an aggressive approach as younger patients, although
more complex supportive and psychological care is fre-
quently necessary. In Particular, radiotherapy can be delivered
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in radical doses, which is supported by the experience of
Soumarova3 and the review by Gugicˇ and Strojan4. Site effects
of radiotherapy and the inﬂuence on the life quality of patients
5should be considered. On the other hand, radiotherapy can
substitute systematic treatment in some cases.6
Undertreatment of elder patients with breast cancer may
be connected with poorer outcome compared to younger
Fig. 3 – Stages of the disease at diagnosis in patients aged 70+, p
proportion of stages 1 and 2.tinued ).
subjects,7 but Tesarova8 presents evidence that older but
otherwise healthy women can tolerate standard adjuvant
chemotherapy very well and also surgery should not be omit-
ted. The radiotherapy can be delivered in more  patient friendly
schedules than the common practice offers.9–11
One of the very important conditions of both radical and
palliative treatment of elderly patients is adequate nutrition,
eriod 2004–2008. Diagnoses are sorted according to
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hich can improve the treatment results and quality of life.12
adak13 offers a complex insight into the pathogenesis of
umor cachexia and sarcopenia and recommendations for
utritional care of elderly patients.
On the other hand it is important to identify frail patients
ho  will not derive beneﬁt from radical procedures and their
uality of life will be impaired. Development of simple and
eliable tools for tailoring of oncological treatment is an object
f contemporary research.14
A part of the patients progress despite treatment or are
n a condition that makes an anticancer treatment impossi-
le. The practical experience with a system of palliative care
s described by Slovacek et al.15 An adequate social support
eems to be a very important aspect of the complex treatment
f senior patients.16
One of most difﬁcult decisions in oncology is related to the
nd of life of oncological patients. The most pressing ques-
ions are discussed by Trivedi.17
Like in other ﬁelds of medicine, the necessity of better
nderstanding the problems of elderly patients also emerged
n oncology. In the year 1999 the International Society of Geri-
tric Oncology (SIOG) was established with a goal to guarantee
rogress and practical achievements for geriatric patients
nd to grant them equal chance of effective treatment as
or younger patients. It seems desirable to create oncoge-
iatric working groups by oncological departments allowing
omplex treatment of seniors, including internal, nutritive,
ehabilitation and psychological aspects and to establish a
ubspecialisation of oncology – gerontooncology. We  hope,
hat the present issue will contribute to this effort.
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